Microbot Medical Analyst Price Targets

Microbot Medical Inc

MBOTNASDAQ

Trade with Public

$0.9528

0.00280.29%

最終更新: Oct 20, 3:02 AM

$0.9600

0.011.05%

概要ニュース業績予想イベント目標株価財務センチメント株主構成比較オプション株式レポート

Microbot Medical Analyst Price Targets

Wall Street analyst price targets and consensus rating for Microbot Medical (MBOT).

Price Target Range — 8 Quarters

Analyst Consensus — 4 Analysts

4Buy

Consensus RatingBuy# Analysts4Avg. Consensus PT$6Upside to Avg. PT+564.6%

Rating Trend — Last 9 Months

Recent Analyst Actions

すべての評価を見る →

Date	Firm	Analyst	Action	Rating Change	Price Target
Aug 14, 2026	B. Riley Securities	Anderson Schock	PT Cut	Buy	$5→$4
Jun 3, 2026	LUCID CAPITAL MARKETS	Alex Nowark	Initiate	Buy	$4
Apr 14, 2026	HC Wainwright & Co.	Raghuram Selvaraju	Maintained	Buy	$12
Feb 10, 2026	B. Riley Securities	Anderson Schock	Initiate	Buy	$5
Dec 3, 2025	Roth Capital	Kyle Bauser	Initiate	Buy	$6
Nov 28, 2025	HC Wainwright & Co.	Raghuram Selvaraju	Maintained	Buy	$12
Oct 15, 2025	HC Wainwright & Co.	Raghuram Selvaraju	Maintained	Buy	$12
Sep 11, 2025	HC Wainwright & Co.	Raghuram Selvaraju	PT Raise	Buy	$9→$12
Apr 10, 2025	HC Wainwright & Co.	Raghuram Selvaraju	Maintained	Buy	$9
Jan 24, 2025	HC Wainwright & Co.	Raghuram Selvaraju	PT Raise	Buy	$7→$9
Jun 3, 2024	HC Wainwright & Co.	Raghuram Selvaraju	Maintained	Buy	$7
Apr 16, 2024	HC Wainwright & Co.	Raghuram Selvaraju	PT Cut	Buy	$8→$7

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
B. Riley Securities Reiterates Buy on Microbot Medical, Lowers Price Target to $4

B. Riley Securities analyst Anderson Schock reiterates Microbot Medical (NASDAQ:MBOT) with a Buy and lowers the price target from $5 to $4.

Benzinga Newsdesk

PRO
LUCID CAPITAL MARKETS Initiates Coverage On Microbot Medical with Buy Rating, Announces Price Target of $4

LUCID CAPITAL MARKETS analyst Alex Nowark initiates coverage on Microbot Medical (NASDAQ:MBOT) with a Buy rating and announces Price Target of $4.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Microbot Medical, Maintains $12 Price Target

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Microbot Medical (NASDAQ:MBOT) with a Buy and maintains $12 price target.

Benzinga Newsdesk

This Microbot Medical Analyst Begins Coverage On A Bullish Note; Here Are Top 2 Initiations For Tuesday

Avi Kapoor

PRO
B. Riley Securities Initiates Coverage On Microbot Medical with Buy Rating, Announces Price Target of $5

B. Riley Securities analyst Anderson Schock initiates coverage on Microbot Medical (NASDAQ:MBOT) with a Buy rating and announces Price Target of $5.

Benzinga Newsdesk

PRO
Roth Capital Initiates Coverage On Microbot Medical with Buy Rating, Announces Price Target of $5.5

Roth Capital analyst Kyle Bauser initiates coverage on Microbot Medical (NASDAQ:MBOT) with a Buy rating and announces Price Target of $5.5.

Benzinga Newsdesk

Microbot Medical Inc

Microbot Medical Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
B. Riley Securities Reiterates Buy on Microbot Medical, Lowers Price Target to $4

PRO
LUCID CAPITAL MARKETS Initiates Coverage On Microbot Medical with Buy Rating, Announces Price Target of $4

PRO
HC Wainwright & Co. Reiterates Buy on Microbot Medical, Maintains $12 Price Target

This Microbot Medical Analyst Begins Coverage On A Bullish Note; Here Are Top 2 Initiations For Tuesday

PRO
B. Riley Securities Initiates Coverage On Microbot Medical with Buy Rating, Announces Price Target of $5

PRO
Roth Capital Initiates Coverage On Microbot Medical with Buy Rating, Announces Price Target of $5.5

ニュース

パートナーシップ

ベンジンガ・グローバル

Microbot Medical Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
B. Riley Securities Reiterates Buy on Microbot Medical, Lowers Price Target to $4

PRO
LUCID CAPITAL MARKETS Initiates Coverage On Microbot Medical with Buy Rating, Announces Price Target of $4

PRO
HC Wainwright & Co. Reiterates Buy on Microbot Medical, Maintains $12 Price Target

This Microbot Medical Analyst Begins Coverage On A Bullish Note; Here Are Top 2 Initiations For Tuesday

PRO
B. Riley Securities Initiates Coverage On Microbot Medical with Buy Rating, Announces Price Target of $5

PRO
Roth Capital Initiates Coverage On Microbot Medical with Buy Rating, Announces Price Target of $5.5

People Also Watch

People Also Watch

Microbot Medical Inc

Microbot Medical Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROB. Riley Securities Reiterates Buy on Microbot Medical, Lowers Price Target to $4

PROLUCID CAPITAL MARKETS Initiates Coverage On Microbot Medical with Buy Rating, Announces Price Target of $4

PROHC Wainwright & Co. Reiterates Buy on Microbot Medical, Maintains $12 Price Target

This Microbot Medical Analyst Begins Coverage On A Bullish Note; Here Are Top 2 Initiations For Tuesday

PROB. Riley Securities Initiates Coverage On Microbot Medical with Buy Rating, Announces Price Target of $5

PRORoth Capital Initiates Coverage On Microbot Medical with Buy Rating, Announces Price Target of $5.5

ニュース

パートナーシップ

ベンジンガ・グローバル

Microbot Medical Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROB. Riley Securities Reiterates Buy on Microbot Medical, Lowers Price Target to $4

PROLUCID CAPITAL MARKETS Initiates Coverage On Microbot Medical with Buy Rating, Announces Price Target of $4

PROHC Wainwright & Co. Reiterates Buy on Microbot Medical, Maintains $12 Price Target

This Microbot Medical Analyst Begins Coverage On A Bullish Note; Here Are Top 2 Initiations For Tuesday

PROB. Riley Securities Initiates Coverage On Microbot Medical with Buy Rating, Announces Price Target of $5

PRORoth Capital Initiates Coverage On Microbot Medical with Buy Rating, Announces Price Target of $5.5

People Also Watch

People Also Watch

PRO
B. Riley Securities Reiterates Buy on Microbot Medical, Lowers Price Target to $4

PRO
LUCID CAPITAL MARKETS Initiates Coverage On Microbot Medical with Buy Rating, Announces Price Target of $4

PRO
HC Wainwright & Co. Reiterates Buy on Microbot Medical, Maintains $12 Price Target

PRO
B. Riley Securities Initiates Coverage On Microbot Medical with Buy Rating, Announces Price Target of $5

PRO
Roth Capital Initiates Coverage On Microbot Medical with Buy Rating, Announces Price Target of $5.5

PRO
B. Riley Securities Reiterates Buy on Microbot Medical, Lowers Price Target to $4

PRO
LUCID CAPITAL MARKETS Initiates Coverage On Microbot Medical with Buy Rating, Announces Price Target of $4

PRO
HC Wainwright & Co. Reiterates Buy on Microbot Medical, Maintains $12 Price Target

PRO
B. Riley Securities Initiates Coverage On Microbot Medical with Buy Rating, Announces Price Target of $5

PRO
Roth Capital Initiates Coverage On Microbot Medical with Buy Rating, Announces Price Target of $5.5